Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-006637

Options or other derivatives

  • SVP, Specialty Commercial acquired 356,202 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Todisco Joseph SVP, Specialty Commercial 2020-02-27 Grant or award · Restricted Stock Units +118,734 118,734 D
Todisco Joseph SVP, Specialty Commercial 2020-02-27 Grant or award · Performance-Based Restricted Stock Units +237,468 237,468 D
Loading xslF345X03/doc4.xml…